VA slashes use of hydroxychloroquine to treat COVID-19 patients

VA slashes use of hydroxychloroquine to treat COVID-19 patients

The VA health system has stopped nearly all use of hydroxychloroquine to treat COVID-19 patients, Veterans Affairs Secretary Robert Wilkie said at a House hearing on Thursday.

Wilkie said VA hospitals "ratcheted it down" to just three prescriptions in the last week as new research highlighted possible dangers and other possible treatments became available, the Associated Press reported. "I expect that to continue in the future," Wilkie added. He defended the VA's initial use of hydroxychloroquine to treat COVID-19 patients, saying there were few treatment options at the time.

The VA health system has recently turned to the antiviral drug remdesivir and convalescent plasma from people who have recovered from infection with the new coronavirus, the AP reported.

The VA's website says 13,657 veterans have been infected with the new coronavirus, and 1,200 have died. Some veterans' groups demanded the VA explain its use of hydroxychloroquine after data showed that the drug provided no benefit to veterans who received it. The death rate for veterans who received the drug plus usual care was 28 percent compared with 11 percent of those who received usual care alone, the AP reported.


Explore further

Follow the latest news on the coronavirus (COVID-19) outbreak

More information: AP News Article

Copyright © 2020 HealthDay. All rights reserved.

Citation: VA slashes use of hydroxychloroquine to treat COVID-19 patients (2020, June 1) retrieved 14 August 2020 from https://medicalxpress.com/news/2020-06-va-slashes-hydroxychloroquine-covid-patients.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
5 shares

Feedback to editors

User comments